1. Home
  2. ADXN vs PAVM Comparison

ADXN vs PAVM Comparison

Compare ADXN & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • PAVM
  • Stock Information
  • Founded
  • ADXN 2002
  • PAVM 2014
  • Country
  • ADXN Switzerland
  • PAVM United States
  • Employees
  • ADXN N/A
  • PAVM N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • PAVM Medical/Dental Instruments
  • Sector
  • ADXN Health Care
  • PAVM Health Care
  • Exchange
  • ADXN Nasdaq
  • PAVM Nasdaq
  • Market Cap
  • ADXN 8.0M
  • PAVM 8.0M
  • IPO Year
  • ADXN N/A
  • PAVM 2016
  • Fundamental
  • Price
  • ADXN $8.73
  • PAVM $0.47
  • Analyst Decision
  • ADXN Strong Buy
  • PAVM Strong Buy
  • Analyst Count
  • ADXN 1
  • PAVM 1
  • Target Price
  • ADXN $30.00
  • PAVM $19.00
  • AVG Volume (30 Days)
  • ADXN 1.0K
  • PAVM 273.7K
  • Earning Date
  • ADXN 09-01-2025
  • PAVM 08-14-2025
  • Dividend Yield
  • ADXN N/A
  • PAVM N/A
  • EPS Growth
  • ADXN N/A
  • PAVM N/A
  • EPS
  • ADXN 0.10
  • PAVM 0.83
  • Revenue
  • ADXN $278,508.00
  • PAVM $1,020,000.00
  • Revenue This Year
  • ADXN $86.57
  • PAVM N/A
  • Revenue Next Year
  • ADXN N/A
  • PAVM $455.63
  • P/E Ratio
  • ADXN $0.72
  • PAVM $0.56
  • Revenue Growth
  • ADXN N/A
  • PAVM N/A
  • 52 Week Low
  • ADXN $6.51
  • PAVM $0.30
  • 52 Week High
  • ADXN $13.27
  • PAVM $1.90
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 58.21
  • PAVM 44.20
  • Support Level
  • ADXN $7.51
  • PAVM $0.43
  • Resistance Level
  • ADXN $8.21
  • PAVM $0.45
  • Average True Range (ATR)
  • ADXN 0.17
  • PAVM 0.05
  • MACD
  • ADXN 0.11
  • PAVM 0.00
  • Stochastic Oscillator
  • ADXN 100.00
  • PAVM 71.88

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

About PAVM PAVmed Inc.

PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.

Share on Social Networks: